Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal
血浆中IL-6和MCP-1水平升高可选择性地识别出在停用TKI后能更好地维持分子缓解的CML患者。
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-023-01440-6
Pavlovsky, Carolina; Vasconcelos Cordoba, Bianca; Sanchez, María Belén; Moiraghi, Beatriz; Varela, Ana; Custidiano, Rosario; Fernandez, Isolda; Freitas, Maria Josefina; Ventriglia, Maria Verónica; Bendek, Georgina; Mariano, Romina; Mela Osorio, María José; Pavlovsky, Miguel Angel; de Labanca, Ana García; Foncuberta, Cecilia; Giere, Isabel; Vera, Masiel; Juni, Mariana; Mordoh, Jose; Sanchez Avalos, Julio Cesar; Cueto, Gerardo; Miranda, Silvia; Levy, Estrella Mariel; Bianchini, Michele